ArriVent BioPharma, Inc. (AVBP) Earnings
NASDAQ·Healthcare·Biotechnology
$13.81
+12.92%
Mkt Cap $658.26M
EPS — Estimate vs Actual
Mkt Cap
$658.26M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53
NASDAQ·Healthcare·Biotechnology
$13.81
+12.92%
Mkt Cap $658.26M
Mkt Cap
$658.26M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53